(WO/1996/003122) USE OF GABAPENTIN IN THE TREATMENT OF ANXIETY AND PANIC
- Biblio. Data
- Description
- Claims
- National Phase
- Notices
- Documents
| Latest bibliographic data on file with the International Bureau
| |||||||||||||||||||
| |||||||||||||||||||
| IPC: | A61K 31/197 (2006.01), C07K 14/47 (2006.01), A61K 38/00 (2006.01) | ||||||||||||||||||
| Applicant: | WARNER-LAMBERT COMPANY [US/US]; 201 Tabor Road, Morris Plains, NJ 07950 (US). | ||||||||||||||||||
| Inventors: | WOODRUFF, Geoffrey, Neil; (GB). GEE, Nicolas, S.; (GB). SINGH, Lakhbir; (GB). BROWN, Jason, P.; (GB). | ||||||||||||||||||
| Agents: | RYAN, M., Andrea; Warner-Lambert Company, 201 Tabor Road, Morris Plains, NJ 07950 (US). MANSMANN, Ivo et al.; Warner-Lambert Company, Legal Division, Patent Dept., Gödecke AG, Mooswaldallee 1, D-79090 Freiburg (DE). | ||||||||||||||||||
| Priority Data: |
| ||||||||||||||||||
| Title: | USE OF GABAPENTIN IN THE TREATMENT OF ANXIETY AND PANIC | ||||||||||||||||||
| Abstract: | The instant invention is novel uses of known cyclic amino acids. Such compounds as gabapentin are useful in the treatment of anxiety and in the treatment and/or prevention of panic attacks. The partial N-terminal sequence of the gabapentin binding protein has been determined to be identical to the N-terminal sequence of the mature $g(a)¿2?$g(d) subunit of the L-type Ca?2+¿ channel from rabbit skeletal muscle. | ||||||||||||||||||
| Designated States: |
AU, CA, CZ, EE, HU, JP, LT, LV, MX, NZ, PL, RO, RU, SI, SK. European Patent Office (EPO) (AT, BE, CH, DE, DK, ES, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE). | ||||||||||||||||||
| Publication Language: | English (EN) |
| Filing Language: | English (EN) |
